1Cooper, RA (1977) Abnormalities of cell-membrane fluidity in the pathogenesis of disease. N Engl J Med 297, 371–377.
2Hodson, L, Skeaff, CM & Fielding, BA (2008) Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog Lipid Res 47, 348–380.
3Jonas, A, Zorich, NL, Kezdy, KE, et al. (1987) Reaction of discoidal complexes of apolipoprotein A-I and various phosphatidylcholines with lecithin cholesterol acyltransferase. Interfacial effects. J Biol Chem 262, 3969–3974.
4Tsuda, K & Nishio, I (2003) Membrane fluidity and hypertension. Am J Hypertens 16, 259–261.
5Gojova, A & Barakat, AI (2005) Vascular endothelial wound closure under shear stress: role of membrane fluidity and flow-sensitive ion channels. J Appl Physiol 98, 2355–2362.
6Ding, EL, Sun, Q, Campos, H, et al. (2008) Lipophilic index of fatty acid fluidity in erythrocyte and plasma and risk of coronary heart disease (abstract). Circulation 118, S_1089.
7Vaclavik, VA & Christian, EW (2008) Fats: fat and oil products. In Essentials of Food Science, pp. 271–310. New York, NY: Springer Science+Business Media, LLC.
8Hatoum, IJ, Cook, NR, Nelson, JJ, et al. (2011) Lipoprotein-associated phospholipase A2 activity improves risk discrimination of incident coronary heart disease among women. Am Heart J 161, 516–522.
9Rose, G & Blackburn, H (1982) Cardiovascular Survey Method, Monograph Series No. 56, 2nd ed.Geneva: World Health Organization.
10Baylin, A, Kabagambe, EK, Siles, X, et al. (2002) Adipose tissue biomarkers of fatty acid intake. Am J Clin Nutr 76, 750–757.
11 Japanese Conference on Biochemistry of Lipids. (2007) Lipid Bank for Web Database. http://lipidbank.jp/ (updated 2007). Japan Science and Technology Agency and International Medical Center of Japan.
12Pischon, T, Hu, FB, Rexrode, KM, et al. (2008) Inflammation, the metabolic syndrome, and risk of coronary heart disease in women and men. Atherosclerosis 197, 392–399.
13Qi, L, Rimm, E, Liu, S, et al. (2005) Dietary glycemic index, glycemic load, cereal fiber, and plasma adiponectin concentration in diabetic men. Diabetes Care 28, 1022–1028.
14Wolf, AM, Hunter, DJ, Colditz, GA, et al. (1994) Reproducibility and validity of a self-administered physical activity questionnaire. Int J Epidemiol 23, 991–999.
15McCullough, ML, Feskanich, D, Stampfer, MJ, et al. (2002) Diet quality and major chronic disease risk in men and women: moving toward improved dietary guidance. Am J Clin Nutr 76, 1261–1271.
16van Meer, G, Voelker, DR & Feigenson, GW (2008) Membrane lipids: where they are and how they behave. Nat Rev Mol Cell Biol 9, 112–124.
17Zicha, J, Kunes, J & Devynck, M-A (1999) Abnormalities of membrane function and lipid metabolism in hypertension – a review. Am J Hypertens 12, 315–331.
18Tsuda, K (2006) Adiponectin and membrane fluidity of erythrocytes in normotensive and hypertensive men. Obesity 14, 1505–1510.
19Tsuda, K (2010) Oxidative stress and membrane fluidity of red blood cells in hypertensive and normotensive men: an electron spin resonance investigation. Int Heart J 51, 121–124.
20Pilch, PF, Thompson, PA & Czech, MP (1980) Coordinate modulation of d-glucose transport activity and bilayer fluidity in plasma membranes derived from control and insulin-treated adipocytes. Proc Natl Acad Sci U S A 77, 915–918.
21Brasitus, TA, Dudeja, PK, Bolt, MJ, et al. (1989) Dietary triacylglycerol modulates sodium-dependent d-glucose transport, fluidity and fatty acid composition of rat small intestinal brush-border membrane. Biochim Biophys Acta 979, 177–186.
22Muramatsu, K, Maitani, Y, Takayama, K, et al. (1999) The relationship between the rigidity of the liposomal membrane and the absorption of insulin after nasal administration of liposomes modified with an enhancer containing insulin in rabbits. Drug Dev Ind Pharm 25, 1099–1105.
23Wiernsperger, NF & Bailey, CJ (1999) The antihyperglycaemic effect of metformin: therapeutic and cellular mechanisms. Drugs 58, Suppl. 1, 31–39, .
24Sola, R, Baudet, MF, Motta, C, et al. (1990) Effects of dietary fats on the fluidity of human high-density lipoprotein: influence of the overall composition and phospholipid fatty acids. Biochim Biophys Acta 1043, 43–51.
25Parks, JS, Huggins, KW, Gebre, AK, et al. (2000) Phosphatidylcholine fluidity and structure affect lecithin:cholesterol acyltransferase activity. J Lipid Res 41, 546–553.
26Berrougui, H, Isabelle, M, Cloutier, M, et al. (2007) Age-related impairment of HDL-mediated cholesterol efflux. J Lipid Res 48, 328–336.
27Reed, CF (1968) Phospholipid exchange between plasma and erythrocytes in man and the dog. J Clin Invest 47, 749–760.
28Emken, EA, Rohwedder, WK, Dutton, HJ, et al. (1979) Incorporation of deuterium-labeled cis- and trans-9-octadecenoic acids in humans: plasma, erythrocyte, and platelet phospholipids. Lipids 14, 547–554.
29Hu, FB, Manson, JE & Willett, WC (2001) Types of dietary fat and risk of coronary heart disease: a critical review. J Am Coll Nutr 20, 5–19.
30Sacks, FM & Katan, M (2002) Randomized clinical trials on the effects of dietary fat and carbohydrate on plasma lipoproteins and cardiovascular disease. Am J Med 113, Suppl. 9B, 13S–24S.
31Field, CJ, Ryan, EA, Thomson, AB, et al. (1990) Diet fat composition alters membrane phospholipid composition, insulin binding, and glucose metabolism in adipocytes from control and diabetic animals. J Biol Chem 265, 11143–11150.
32Ginsberg, BH, Chatterjee, P & Yorek, MA (1991) Insulin sensitivity is increased in Friend erythroleukemia cells enriched in polyunsaturated fatty acid. Receptor 1, 155–166.
33Haugaard, SB, Madsbad, S, Hoy, CE, et al. (2006) Dietary intervention increases n-3 long-chain polyunsaturated fatty acids in skeletal muscle membrane phospholipids of obese subjects. Implications for insulin sensitivity. Clin Endocrinol (Oxf) 64, 169–178.
34Mozaffarian, D & Wu, JH (5000) Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. J Am Coll Cardiol 58, 2047–2067.
35Mozaffarian, D, Katan, MB, Ascherio, A, et al. (2006) Trans fatty acids and cardiovascular disease. N Engl J Med 354, 1601–1613.
36Hulman, G, Fraser, I, Pearson, HJ, et al. (1982) Agglutination of intralipid by sera of acutely ill patients. Lancet ii, 1426–1427.
37Lindh, A, Johansson, B, Lindholm, M, et al. (1985) Agglutinate formation in serum samples mixed with intravenous fat emulsions. Crit Care Med 13, 151–154.
38Hulman, G (1995) The pathogenesis of fat embolism. J Pathol 176, 3–9.